ATF6 and hepatocellular carcinoma: Nevertheless, the malignant behavior of HCC cells was not influenced by GSK2850163 and Ceapin‐A7, inhibitors of IRE1‐XBP1 and ATF6 pathway, respectively (Figures S1, S3, and S4).